Journal article
Phosphorylation of tropomodulin1 contributes to the regulation of actin filament architecture in cardiac muscle
The FASEB journal, Vol.28(9), pp.3987-3995
09/2014
Handle:
https://hdl.handle.net/2376/105999
PMCID: PMC4139905
PMID: 24891520
Abstract
Tropomodulin1 (Tmod1) is an actin-capping protein that plays an important role in actin filament pointed-end dynamics and length in striated muscle. No mechanisms have been identified to explain how Tmod1's functional properties are regulated. The purpose of this investigation was to explore the functional significance of the phosphorylation of Tmod1 at previously identified Thr54. Rat cardiomyocytes were assessed for phosphorylation of Tmod1 using Pro-Q Diamond staining and (32)P labeling. Green fluorescent protein-tagged phosphorylation-mimic (T54E) and phosphorylation-deficient (T54A) versions of Tmod1 were expressed in cultured cardiomyocytes, and the ability of these mutants to assemble and restrict actin lengths was observed. We report for the first time that Tmod1 is phosphorylated endogenously in cardiomyocytes, and phosphorylation at Thr54 causes a significant reduction in the ability of Tmod1 to assemble to the pointed end compared with that of the wild type (WT; 48 vs. 78%, respectively). In addition, overexpression of Tmod1-T54E restricts actin filament lengths by only ∼3%, whereas Tmod1-WT restricts the lengths significantly by ∼8%. Finally, Tmod1-T54E altered the actin filament-capping activity in polymerization assays. Taken together, our data suggest that pointed-end assembly and Tmod1's thin filament length regulatory function are regulated by its phosphorylation state.
Metrics
5 Record Views
Details
- Title
- Phosphorylation of tropomodulin1 contributes to the regulation of actin filament architecture in cardiac muscle
- Creators
- Katherine T Bliss - Department of Cellular and Molecular Medicine and Sarver Molecular Cardiovascular Research Program, University of Arizona, Tucson, Arizona, USATakehiro Tsukada - Department of Cellular and Molecular Medicine and Sarver Molecular Cardiovascular Research Program, University of Arizona, Tucson, Arizona, USAStefanie Mares Novak - Department of Cellular and Molecular Medicine and Sarver Molecular Cardiovascular Research Program, University of Arizona, Tucson, Arizona, USAMaxim V Dorovkov - Department of Pharmacology andSamar P Shah - Department of Neuroscience and Cell Biology, Robert Wood Johnson Medical School, Piscataway, New Jersey, USA; andChinedu Nworu - Department of Cellular and Molecular Medicine and Sarver Molecular Cardiovascular Research Program, University of Arizona, Tucson, Arizona, USAAlla S Kostyukova - Department of Neuroscience and Cell Biology, Robert Wood Johnson Medical School, Piscataway, New Jersey, USA; and School of Chemical Engineering and Bioengineering, Washington State University, Pullman, Washington, USACarol C Gregorio - Department of Cellular and Molecular Medicine and Sarver Molecular Cardiovascular Research Program, University of Arizona, Tucson, Arizona, USA; gregorio@email.arizona.edu
- Publication Details
- The FASEB journal, Vol.28(9), pp.3987-3995
- Academic Unit
- Chemical Engineering and Bioengineering, School of
- Publisher
- United States
- Grant note
- 1F31HL 117520 / NHLBI NIH HHS HL108625 / NHLBI NIH HHS R01 GM081688 / NIGMS NIH HHS R01 HL083146 / NHLBI NIH HHS R01 HL081386 / NHLBI NIH HHS GM081688 / NIGMS NIH HHS R01 HL108625 / NHLBI NIH HHS F31 HL117520 / NHLBI NIH HHS HL081386 / NHLBI NIH HHS HL083146 / NHLBI NIH HHS
- Identifiers
- 99900546720701842
- Language
- English
- Resource Type
- Journal article